129 related articles for article (PubMed ID: 14676134)
1. Should B-type natriuretic peptide be measured routinely to guide the diagnosis and management of chronic heart failure?
Packer M
Circulation; 2003 Dec; 108(24):2950-3. PubMed ID: 14676134
[No Abstract] [Full Text] [Related]
2. The natriuretic peptides in heart failure.
Richards AM
Basic Res Cardiol; 2004 Mar; 99(2):94-100. PubMed ID: 14963668
[TBL] [Abstract][Full Text] [Related]
3. Brain natriuretic peptide: clinical and research challenges.
Carrillo-Jimenez R; Borzak S; Hennekens CH
J Cardiovasc Pharmacol Ther; 2007 Jun; 12(2):85-8. PubMed ID: 17562778
[TBL] [Abstract][Full Text] [Related]
4. [Should B-type natriuretic peptide (BNP) be used in daily practice?].
Sarasin FP
Rev Med Suisse; 2005 Nov; 1(42):2726, 2728-30. PubMed ID: 16366447
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness of B-type natriuretic peptide (BNP) for the diagnosis of new-onset heart failure with a preserved left ventricular systolic function in longstanding hypertensive patients with acute dyspnea].
Arquès S; Roux E; Sbragia P; Pieri B; Gélisse R; Luccioni R; Ambrosi P
Arch Mal Coeur Vaiss; 2007 Feb; 100(2):113-20. PubMed ID: 17474496
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers in heart failure management.
Isaac DL
Curr Opin Cardiol; 2008 Mar; 23(2):127-33. PubMed ID: 18303525
[TBL] [Abstract][Full Text] [Related]
7. Alterations in plasma B-type natriuretic peptide levels after repair of congenital heart defects: a potential perioperative marker.
Shih CY; Sapru A; Oishi P; Azakie A; Karl TR; Harmon C; Asija R; Adatia I; Fineman JR
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):632-8. PubMed ID: 16515916
[TBL] [Abstract][Full Text] [Related]
8. Clinical status and B-type natriuretic peptide levels in patients with heart failure at hospital discharge.
Oral I; Mistrík J; Náplava R
Herz; 2007 Oct; 32(7):583-8. PubMed ID: 17972033
[TBL] [Abstract][Full Text] [Related]
9. N-terminal B-type natriuretic peptide levels in pediatric patients with congestive heart failure undergoing cardiac surgery.
Walsh R; Boyer C; LaCorte J; Parnell V; Sison C; Chowdhury D; Ojamaa K
J Thorac Cardiovasc Surg; 2008 Jan; 135(1):98-105. PubMed ID: 18179925
[TBL] [Abstract][Full Text] [Related]
10. Independent value of echocardiography and N-terminal pro-natriuretic Peptide for the prediction of major outcomes in patients with suspected heart failure.
Lim TK; Hayat SA; Gaze D; Celik E; Collinson P; Senior R
Am J Cardiol; 2007 Sep; 100(5):870-5. PubMed ID: 17719336
[TBL] [Abstract][Full Text] [Related]
11. Low levels of B-type natriuretic peptide predict poor clinical outcomes in patients with chronic and advanced heart failure.
Sun TW; Wang LX
Med Hypotheses; 2007; 68(3):677-9. PubMed ID: 16899344
[TBL] [Abstract][Full Text] [Related]
12. Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational Study.
Strunk A; Bhalla V; Clopton P; Nowak RM; McCord J; Hollander JE; Duc P; Storrow AB; Abraham WT; Wu AH; Steg G; Perez A; Kazanegra R; Herrmann HC; Aumont MC; McCullough PA; Maisel A
Am J Med; 2006 Jan; 119(1):69.e1-11. PubMed ID: 16431187
[TBL] [Abstract][Full Text] [Related]
13. B-type natriuretic peptide: a diagnostic, prognostic, and therapeutic tool in heart failure.
Prahash A; Lynch T
Am J Crit Care; 2004 Jan; 13(1):46-53; quiz 54-5. PubMed ID: 14735647
[TBL] [Abstract][Full Text] [Related]
14. N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure.
Bruch C; Reinecke H; Stypmann J; Rothenburger M; Schmid C; Breithardt G; Wichter T; Gradaus R
J Heart Lung Transplant; 2006 Sep; 25(9):1135-41. PubMed ID: 16962477
[TBL] [Abstract][Full Text] [Related]
15. B-type natriuretic peptide assays for detecting heart failure in the elderly: same value as those in the younger?
Rutten FH; Hoes AW
Int J Cardiol; 2008 Apr; 125(2):161-5. PubMed ID: 17963872
[TBL] [Abstract][Full Text] [Related]
16. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
[TBL] [Abstract][Full Text] [Related]
17. [The importance of plasma B-type natriuretic peptide levels in cardiovascular diseases].
Duygu H; Türk U; Zoghi M; Nalbantgil S
Anadolu Kardiyol Derg; 2005 Dec; 5(4):305-11. PubMed ID: 16330398
[TBL] [Abstract][Full Text] [Related]
18. [Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population].
El Mahmoud R; Alibay Y; Brun-Ney D; Boulard JC; Dubourg O; Puy H; Jondeau G
Arch Mal Coeur Vaiss; 2006 Mar; 99(3):201-7. PubMed ID: 16618022
[TBL] [Abstract][Full Text] [Related]
19. Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide.
Miller WL; Burnett JC; Hartman KA; Henle MP; Burritt MF; Jaffe AS
Am J Cardiol; 2005 Sep; 96(6):837-41. PubMed ID: 16169373
[TBL] [Abstract][Full Text] [Related]
20. The use of B-type natriuretic peptide in the management of elderly patients with acute dyspnoea.
Mueller C; Laule-Kilian K; Frana B; Rodriguez D; Rudez J; Scholer A; Buser P; Pfisterer M; Perruchoud AP
J Intern Med; 2005 Jul; 258(1):77-85. PubMed ID: 15953135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
